BOOM

Trending Searches

    SUPPORT
    BOOM

    Trending News

      • Fact Check 
        • Fast Check
        • Politics
        • Business
        • Entertainment
        • Social
        • Sports
        • World
      • Law
      • Explainers
      • News 
        • All News
      • Decode 
        • Impact
        • Scamcheck
        • Life
        • Voices
      • Media Buddhi 
        • Digital Buddhi
        • Senior Citizens
        • Videos
      • Web Stories
      • BOOM Research
      • BOOM Labs
      • Deepfake Tracker
      • Videos 
        • Facts Neeti
      • Home-icon
        Home
      • About Us-icon
        About Us
      • Authors-icon
        Authors
      • Team-icon
        Team
      • Careers-icon
        Careers
      • Internship-icon
        Internship
      • Contact Us-icon
        Contact Us
      • Methodology-icon
        Methodology
      • Correction Policy-icon
        Correction Policy
      • Non-Partnership Policy-icon
        Non-Partnership Policy
      • Cookie Policy-icon
        Cookie Policy
      • Grievance Redressal-icon
        Grievance Redressal
      • Republishing Guidelines-icon
        Republishing Guidelines
      • Fact Check-icon
        Fact Check
        Fast Check
        Politics
        Business
        Entertainment
        Social
        Sports
        World
      • Law-icon
        Law
      • Explainers-icon
        Explainers
      • News-icon
        News
        All News
      • Decode-icon
        Decode
        Impact
        Scamcheck
        Life
        Voices
      • Media Buddhi-icon
        Media Buddhi
        Digital Buddhi
        Senior Citizens
        Videos
      • Web Stories-icon
        Web Stories
      • BOOM Research-icon
        BOOM Research
      • BOOM Labs-icon
        BOOM Labs
      • Deepfake Tracker-icon
        Deepfake Tracker
      • Videos-icon
        Videos
        Facts Neeti
      Trending Tags
      TRENDING
      • #Operation Sindoor
      • #Pahalgam Terror Attack
      • #Narendra Modi
      • #Rahul Gandhi
      • #Waqf Amendment Bill
      • #Arvind Kejriwal
      • #Deepfake
      • #Artificial Intelligence
      • Home
      • Coronavirus
      • Health Ministry Refutes Media...
      Coronavirus

      Health Ministry Refutes Media Reports Of Serum, Bharat Biotech EUA Rejected

      The subject expert committee at the national regulator has asked the two vaccine manufacturers to reappear with more data

      By - Shachi Sutaria |
      Published -  9 Dec 2020 8:19 PM IST
    • Boomlive
      Health Ministry Refutes Media Reports Of Serum, Bharat Biotech EUA Rejected

      The Ministry of Health and Family Welfare took to Twitter to call out a graphic by NDTV that said the Emergency Use Authorization (EUA) requests filed by Serum Institute of India and Bharat Biotech for their COVID-19 vaccines have been rejected.

      Both the vaccine makers presented before the Subject Expert Committee (SEC) meeting held on Wednesday at the Central Drugs Standard Control Organization (CDSCO), The SEC updated its minutes of its meetings stating that both the manufacturers need to return with more data.

      Emergency Use Authorisation is wherein the process of approval of a vaccine/drug is expediated during a health emergency. Unapproved medical products are permitted to be used for prevention and treatment under EUA.


      #FAKENEWS
      The news running on @ndtvindia is Fake News. pic.twitter.com/VZv7uwW5z7

      — Ministry of Health (@MoHFW_INDIA) December 9, 2020

      The Ministry did not give any information other than what is in the tweet. BOOM sought a clarification from the Ministry spokesperson but did not receive a response.

      BOOM contacted both Serum Institute and Bharat Biotech who declined to comment on the latest developments.

      Other news organizations such as CNBC TV 18 and India Today reported citing sources that the SEC found that the data provided by both the companies was inadequate to grant approval. Both the vaccine manufacturers have been requested to reappear with more data, trial information and documents to seek further approval.

      #BREAKING | Sources say Emergency Use Authorization not granted to Bharat Biotech & Serum Institute of India. SEC seeks more data from Serum Institute & Bharat Biotech. Both to come back again to SEC with more data, trials information & documents#COVID19 #CovidVaccine pic.twitter.com/F2TjmRk6E4

      — CNBC-TV18 (@CNBCTV18Live) December 9, 2020


      #BREAKING
      No emergency use nod to Serum Institute, Bharat Biotech yet#5iveLIVE #CoronaVaccine #COVID19 | @ShivAroor @Milan_reports pic.twitter.com/xBmthJeOvA

      — IndiaToday (@IndiaToday) December 9, 2020

      CNN News 18 also reported citing sources that the Emergency Use Authorisation was 'rejected' by DGCI.

      #NewsAlert | Emergency Use Authorisation rejected for SII & Bharat Biotech vaccines by DGCI.

      DGCI cites lack of data: Sources.@snehamordani with the details.

      Join the broadcast with @AnchorAnandN on #NationAt5. pic.twitter.com/OReyNZlQoE

      — News18 (@CNNnews18) December 9, 2020


      BOOM looked at NDTV's coverage to understand what was being reported at the time when the news of the proposals being rejected was shared. The graphic on the screen as well as the anchor said that the proposal was rejected.

      The reporter, however, is heard saying, "The committee has recommended that they (Serum Institute of India and Bharat Biotech) need to give in more data. But what we would want to really highlights to our viewers at this point of time is that this decision is not to be seen as a finality sort of way because the job of the expert committee is to give recommendations to the regulators. The decision of approving a vaccine is not taken in one meeting alone."

      Normally, the CDSCO uploads the minutes of the meetings that are held for drug and vaccine approval on its website. The members of the SEC deliberate and analyse the data presented to them in the meetings and ask for more data if they feel that it is insufficient. Before they began their clinical trials, both Serum and Bharat Biotech were even then asked to reappear before the committee with adequate data.

      The SEC has asked both the vaccine manufacturers to return with more data on the safety and immunogenicity of the vaccines.

      Currently, Pfizer, Serum Institute, and Bharat Biotech applied for EUA to the CDSCO. While the other two are undergoing Phase 3 trials, Pfizer has not conducted any trials in the country.

      Also Read:COVID-19 Vaccines For India: All You Need To Know
      Also Read:30 Cr Indians To Be Prioritised For COVID-19 Vaccination: Health Ministry

      (Note: This story has been updated with the minutes of the SEC meeting)

      Tags

      Ministry of Healh and Family Welfareserum institute of indiacdscoDCGIbharat biotechCOVID-19NDTV
      Read Full Article
      Next Story
      Our website is made possible by displaying online advertisements to our visitors.
      Please consider supporting us by disabling your ad blocker. Please reload after ad blocker is disabled.
      X

      Subscribe to BOOM Newsletters

      👉 No spam, no paywall — but verified insights.

      Please enter a Email Address
      Subscribe for free!

      Stay Ahead of Misinformation!

      Please enter a Email Address
      Subscribe Now🛡️ 100% Privacy Protected | No Spam, Just Facts
      By subscribing, you agree with the Terms & conditions and Privacy Policy connected to the offer

      Thank you for subscribing!

      You’re now part of the BOOM community.

      Or, Subscribe to receive latest news via email
      Subscribed Successfully...
      Copy HTMLHTML is copied!
      There's no data to copy!